» Articles » PMID: 30404975

The Effect of Colostrum Intake on Osteoprotegerin and Bone Metabolic Markers in the Blood of Newborn Calves During the First Week of Life

Overview
Journal J Vet Med Sci
Date 2018 Nov 9
PMID 30404975
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to elucidate the bone metabolic status after taking colostrum in newborn calves. Fourteen neonatal calves were randomly allocated to two groups fed either unheated or heated (60°C, 30 min) colostrum three times on the first day (2 l every 10 hr; 6 l in total). Heat treatment on colostrum was to reduce the bone metabolic markers assumed as heat-sensitive. The concentrations of four bone metabolic markers (the enzymes from bone cells or the bone collagen fragments) and a bone protective protein, osteoprotegerin (OPG), were measured in the blood of calves during a week after the birth and in the colostrum. The colostral concentrations of four bone metabolic markers were reduced by heating. Then those circulatory markers peaked after colostrum intake in the calves fed unheated colostrum; whereas those fed heated colostrum did not show such changes. However, the plasma tartrate resistant acid phosphatase 5b (TRAP5b) activity was transiently increased after taking colostrum in both groups. Meanwhile, heating did not decrease colostral OPG and there was no significant rise in the serum OPG concentrations after the first colostrum intake in both groups. The study revealed that the blood concentrations of studied bone metabolic markers depended on those colostral values except for TRAP5b. Based on the plasma TRAP5b changes, accelerated formation of premature osteoclast cells may be induced by colostrum intake. Meanwhile, colostral OPG absorption is less likely to impact on its circulating levels.

Citing Articles

Consecutive changes in serum alkaline phosphatase isoenzyme 3 activities in Holstein heifers during the first 18 months of life.

Chiba A, Hatate K, Onomi R, Kawashima C, Hanada M, Moriyama T J Vet Med Sci. 2020; 82(11):1643-1647.

PMID: 32963214 PMC: 7719893. DOI: 10.1292/jvms.20-0306.

References
1.
Hofbauer L, Khosla S, Dunstan C, Lacey D, Boyle W, Riggs B . The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res. 2000; 15(1):2-12. DOI: 10.1359/jbmr.2000.15.1.2. View

2.
Ogueh O, Sooranna S, Nicolaides K, Johnson M . The relationship between leptin concentration and bone metabolism in the human fetus. J Clin Endocrinol Metab. 2000; 85(5):1997-9. DOI: 10.1210/jcem.85.5.6591. View

3.
Alatalo S, Halleen J, Hentunen T, Monkkonen J, Vaananen H . Rapid screening method for osteoclast differentiation in vitro that measures tartrate-resistant acid phosphatase 5b activity secreted into the culture medium. Clin Chem. 2000; 46(11):1751-4. View

4.
Claeys W, Ludikhuyze L, Van Loey A, Hendrickx M . Inactivation kinetics of alkaline phosphatase and lactoperoxidase, and denaturation kinetics of beta-lactoglobulin in raw milk under isothermal and dynamic temperature conditions. J Dairy Res. 2001; 68(1):95-107. DOI: 10.1017/s002202990000460x. View

5.
Janckila A, Takahashi K, Sun S, Yam L . Naphthol-ASBI phosphate as a preferred substrate for tartrate-resistant acid phosphatase isoform 5b. J Bone Miner Res. 2001; 16(4):788-93. DOI: 10.1359/jbmr.2001.16.4.788. View